West Cancer Center

 

West Cancer Center
Avatar

Evolving Treatment for Early HR+ Breast Cancer

By West Cancer Center FEATURING Gregory Vidal
By West Cancer Center FEATURING Gregory Vidal
157 views
February 22, 2023
0 Comments
Login to view comments. Click here to Login
Videos
12:08
West Cancer Center

Patient Selection for CDK4/6i in HR+/HER2- Advanced BC

Feat. G. Vidal
11:33
West Cancer Center

Evolving Treatment for Early HR+ Breast Cancer

Feat. G. Vidal
36:13
Total Health

ESMO 2021 Updates on HER2+ EBC: Surveying the Recent Trials

Feat. L. Schwartzberg
28:58
2021 Virtual ESMO Review

ESMO 2021 Updates on EBC: Neoadjuvant Carboplatin and Ipatasertib in…

Feat. L. Schwartzberg
24:59
Total Health

Palliative Care and Cancer: Pain Management, Emotional Health, and S…

Feat. C. Jackson, K. Parker
12:33
West Cancer Center

2021 ASCO Updates on HR+, HER2- MBC Not Previously Treated With a Ta…

Feat. L. Schwartzberg
11:38
West Cancer Center

1L Approaches in ES-SCLC: Efficacy Data of Atezolizumab and Durvalum…

Feat. J. Porter
15:01
Virtual West Oncology Conference

ASH Updates on MDS: Is Luspatercept Affecting Biomarkers of Erythrop…

Feat. J. Chandler
17:39
Virtual West Oncology Conference

2021 Update on Breast Cancer Brain Metastases: Current Treatment Opt…

Feat. L. Schwartzberg
16:08
Virtual West Oncology Conference

2021 Updates on RC: Does Neoadjuvant Chemo Improve Outcomes? Who Nee…

Feat. N. Vanderwalde
12:40
Virtual West Oncology Conference

2021 Highlights on PARPi for mCRPC & PSMA Imaging: What Is the E…

Feat. D. Vaena
08:44
Virtual West Oncology Conference

2021 Update on ADT Intensification for mCSPC: What Are the Benefits …

Feat. D. Vaena
18:41
Virtual West Oncology Conference

2021 Updates in RCC: Surveying Data for SWOG 1500, Belzutifan, CLEAR…

Feat. B. Somer
15:58
Virtual West Oncology Conference

2021 Updates on mNCSLC: Single Agent IO and Combination Therapy Appr…

Feat. J. Porter
08:19
2020 Virtual ESMO Review

2020 ESMO Update on Immune Checkpoint Inhibitors in eTNBC: Does the …

Feat. L. Schwartzberg
06:06
2020 Virtual ESMO Review

2020 ESMO Update on CDK 4/6 in Adjuvant HR+, HER2- EBC: Does the Add…

Feat. L. Schwartzberg
07:46
2020 Virtual ESMO Review

2020 ESMO Update on CDK 4/6 in Adjuvant HR+, HER2- EBC: How Does Two…

Feat. L. Schwartzberg
33:57
Total Health

2020 Update on Molecular Subtyping in BC: Can MammaPrint, BluePrint,…

Feat. L. Schwartzberg
08:56
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Advanced Prostate Cancer: Is Relugolix Bette…

Feat. B. Somer
13:12
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on PSMA in Prostate Cancer: How Useful Is 18F-DCFP…

Feat. B. Somer
11:01
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on CRPC: Apalutamide vs. Enzalutamide vs. Daroluta…

Feat. B. Somer
11:28
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Melanoma Updates: Optimal Dosing Schedule of Neoadjuvant I…

Feat. A. VanderWalde
16:13
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Melanoma Updates: Combination ICI Post PD-1 Failure, Alter…

Feat. A. VanderWalde
12:25
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Metastatic NSCLC w/o Actionable Mutations: Chemo…

Feat. J. Porter
09:53
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Targeted Therapies for NSCLC: Clinical Activity …

Feat. J. Porter
14:06
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on SCLC: Anti-PD-1/L1 Staple for 1st L Treatment (A…

Feat. J. Porter
20:32
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Innovation and Evolution of Community Oncology: Value Based Care, On…

Feat. L. Schwartzberg
19:07
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

History and Current Status of Community Oncology

Feat. L. Schwartzberg
19:08
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Rectal Cancer Treatment: Pre-operative vs Postoperative RT, Short an…

Feat. N. Dubal
15:37
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Update on Early Stage NSCLC: Role of Screening, Neoadjuvant Therapie…

Feat. J. Porter
07:34
19th Conference of the International Society of Geriatric Oncology

The Role of Radiotherapy in Older Adults with DLBCL: R-CHOPx 3/4 +IS…

Feat. N. Vanderwalde
06:53
19th Conference of the International Society of Geriatric Oncology

Radiation Therapy Continues to Be SoC for Stage 3 NSCLC / There'…

Feat. N. Vanderwalde